BMAL1 and central nervous system cancer: CLOCK and its binding partner, BMAL1, are thought to contribute to glioma proliferation, migration, stemness and metabolic reprogramming [11, 66, 70, 71] and a recent paper proposed that GSCs use BMAL1 and CLOCK to alter these characteristics and gain a physiological advantage [11].